期刊文献+

非小细胞肺癌组织中p16的表达及其与肿瘤细胞增殖的关系 被引量:3

The relationship between the expression of p16 in non-small-cell lung cancer and the proliferation
原文传递
导出
摘要 目的研究p16在人类非小细胞肺癌中的表达意义及与肿瘤细胞增殖的关系。方法应用免疫组织化学(S-P法)检测了80例非小细胞肺癌组织标本和40例肺良性病变组织中p16和细胞增殖核抗原(PCNA)的表达水平。结果(1)非小细胞肺癌组织中p16表达水平(57.5%)显著低于肺良性病变组织(90.0%)(P<0.01);(2)非小细胞肺癌组织中p16基因表达水平降低与肺癌组织学类型,细胞分化程度,患者P-TNM分期,是否有淋巴结转移存在相关性(P<0.05);(3)非小细胞肺癌组织中p16与PCNA表达呈负相关。结论p16基因表达下调与非小细胞肺癌细胞增殖有关,与肿瘤的发生、发展关系密切。 Objective To investigate the significance of p16 expression and the relationship between the expression of p16 and the proliferation. Method The expressions of p16 and PCNA were detected in 80 nsclc samples and 40 lung benign lesion tissues as control by immunohistochemistry(S-P). Results (1)The expression level of pl 6 gene was found to be significantly lower in NSCLC tissues than in benign lesion tissues(P 〈 0.01 ) ;(2 )The expression level of p16 gene was closely related to histological classification, cancer cell differentiation, P-TNM stages and lymph node involvement in lung cancer patients(P 〈 0.05) ;(3)The expression level of PCNA was found to be significantly higher in NSCLC tissues than in benign lesion tissues( P 〈 0.01 ) ; ( 4 ) The reduction of p16 gene expression might be related with the over-proliferation of lung cancer cell(P 〈 0.01). Conclusion The reduction of p16 gene expression is one of the molecular basis of the over-proliferation in NSCLC cell; p16 gene may be related to the pathogenesis and development of lung cancer.
出处 《中国基层医药》 CAS 2006年第4期629-630,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 肺肿瘤 基因 P16 增殖细胞核抗原 细胞分裂 免疫组织化学 Lung neoplasms Genes, p16 Proliferating cell nuclear antigen Cell division Immunohistochemistry
  • 相关文献

参考文献6

二级参考文献27

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2姜彦多,夏书月,戴晓淳,何安光.肺癌CDKN2基因产物表达的研究[J].中华结核和呼吸杂志,1996,19(2):81-83. 被引量:7
  • 3[1]Shapiro GI, Edwards CD, Kobzik L, et al. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res,1995,55(3)∶505-509.
  • 4[2]Sanchez-Cespedes M, Reed AL, Buta M, et al. Inactivation of the INK4A/ARF locus frequently coexists with wtp53 mutations in non-small cell lung cancer. Oncogene,1999,18(43)∶5843-5849.
  • 5[3]Kinoshita I, Akita HD, Mishina T, et al. Altered p16 INK4 and Retinoblastoma protein status in non-small cell lung cancer: Potential synergistic effect which altered p53 protein on proliferative activity. Cancer Res,1996,56(24)∶5557-5562.
  • 6[4]Higashiyama M, Doi O, Kodama K, et al. Retinoblastoma protein expression in lung cancer: an immunochemical analysis. Oncology,1994,51(6)∶544-551.
  • 7[5]Yeager T, Stadler W, Belair C, et al. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res,1995,55(3)∶493-497.
  • 8[6]Yuan J, Knorr J, Altmannsberger M, et al. Expression of p16 and lack of pRB in primary small cell lung cancer. J Pathol,1999,189(3)∶358-362.
  • 9[7]Mack PC, Gandara DR, Bowen C, et al. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma. Clin Cancer Res,1999,5(9)∶2596-2604.
  • 10[8]Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res,1999,5(4)∶791-800.

共引文献18

同被引文献28

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部